Page last updated: 2024-11-10

eugenyl-beta-d-glucopyranoside

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Cross-References

ID SourceID
PubMed CID3084296
CHEMBL ID463487
SCHEMBL ID3613061
MeSH IDM0386473

Synonyms (27)

Synonym
unii-tf6dx3y0j8
18604-50-7
tf6dx3y0j8 ,
eugenyl glucoside
beta-d-glucopyranoside, 2-methoxy-4-(2-propenyl)phenyl
eugenyl beta-d-glucopyranoside
CHEMBL463487 ,
SCHEMBL3613061
(2r,3s,4s,5r,6s)-2-(hydroxymethyl)-6-(2-methoxy-4-prop-2-enylphenoxy)oxane-3,4,5-triol
bdbm50379287
.beta.-d-glucopyranoside, 2-methoxy-4-(2-propenyl)phenyl
eugenyl glucoside th
eugenyl o-.beta.-d-glucopyranoside
glucopyranoside, 4-allyl-2-methoxyphenyl, .beta.-d-
eugenyl .beta.-d-glucopyranosidephenyl
eugenyl glucoside [inci]
citrusin
eugenol o-beta-d-glucopyranoside
eugenol beta-glucoside
eugenyl-o-beta-d-glucopyranoside
NCGC00385694-01
FS-8488
VADSVXSGIFBZLI-IBEHDNSVSA-N
Q27289939
DTXSID201318555
(2s,3r,4s,5s,6r)-2-(4-allyl-2-methoxyphenoxy)-6-(hydroxymethyl)tetrahydro-2h-pyran-3,4,5-triol
AKOS040735496

Research Excerpts

Bioavailability

ExcerptReferenceRelevance
"The ATP-binding cassette transporter P-glycoprotein (P-gp) is known to limit both brain penetration and oral bioavailability of many chemotherapy drugs."( A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
Ambudkar, SV; Brimacombe, KR; Chen, L; Gottesman, MM; Guha, R; Hall, MD; Klumpp-Thomas, C; Lee, OW; Lee, TD; Lusvarghi, S; Robey, RW; Shen, M; Tebase, BG, 2019
)
0.51
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Protein Targets (1)

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Aldo-keto reductase family 1 member B1Rattus norvegicus (Norway rat)IC50 (µMol)30.00000.00041.877310.0000AID654333
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (14)

Assay IDTitleYearJournalArticle
AID1296008Cytotoxic Profiling of Annotated Libraries Using Quantitative High-Throughput Screening2020SLAS discovery : advancing life sciences R & D, 01, Volume: 25, Issue:1
Cytotoxic Profiling of Annotated and Diverse Chemical Libraries Using Quantitative High-Throughput Screening.
AID1346986P-glycoprotein substrates identified in KB-3-1 adenocarcinoma cell line, qHTS therapeutic library screen2019Molecular pharmacology, 11, Volume: 96, Issue:5
A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
AID1346987P-glycoprotein substrates identified in KB-8-5-11 adenocarcinoma cell line, qHTS therapeutic library screen2019Molecular pharmacology, 11, Volume: 96, Issue:5
A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
AID1347160Primary screen NINDS Rhodamine qHTS for Zika virus inhibitors2020Proceedings of the National Academy of Sciences of the United States of America, 12-08, Volume: 117, Issue:49
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
AID1347159Primary screen GU Rhodamine qHTS for Zika virus inhibitors: Unlinked NS2B-NS3 protease assay2020Proceedings of the National Academy of Sciences of the United States of America, 12-08, Volume: 117, Issue:49
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
AID654332Inhibition of advanced glycation end-products formation after 14 days by spectrofluorimetry2012Journal of natural products, Feb-24, Volume: 75, Issue:2
Chemical constituents from the aerial parts of Aster koraiensis with protein glycation and aldose reductase inhibitory activities.
AID1180339Antioxidant activity assessed as AAPH-induced peroxyl radical scavenging activity by oxygen radical absorbance assay2014Bioorganic & medicinal chemistry letters, Aug-01, Volume: 24, Issue:15
Anti-osteoporotic and antioxidant activities of chemical constituents of the aerial parts of Ducrosia ismaelis.
AID1180338Antiosteoporotic activity in mouse RAW264.7 cells assessed as inhibition of RANKL-induced osteoclast formation at 10 uM after 5 days by TRAP assay relative to untreated control2014Bioorganic & medicinal chemistry letters, Aug-01, Volume: 24, Issue:15
Anti-osteoporotic and antioxidant activities of chemical constituents of the aerial parts of Ducrosia ismaelis.
AID1372697Inhibition of mushroom tyrosinase using tyrosine as substrate pretreated for 5 mins followed by substrate addition measured after 20 mins by ELISA2018Bioorganic & medicinal chemistry, 01-15, Volume: 26, Issue:2
Characterization of tyrosinase inhibitory constituents from the aerial parts of Humulus japonicus using LC-MS/MS coupled online assay.
AID736009Antioxidant activity assessed as DPPH radical scavenging activity after 30 mins by microplate reader2013Journal of natural products, Feb-22, Volume: 76, Issue:2
Flavone tetraglycosides and benzyl alcohol glycosides from the Mongolian medicinal plant Dracocephalum ruyschiana.
AID654333Inhibition of Sprague-Dawley rat lens aldose reductase2012Journal of natural products, Feb-24, Volume: 75, Issue:2
Chemical constituents from the aerial parts of Aster koraiensis with protein glycation and aldose reductase inhibitory activities.
AID1180337Antiosteoporotic activity in mouse RAW264.7 cells assessed as inhibition of RANKL-induced osteoclast formation after 5 days by TRAP assay relative to untreated control2014Bioorganic & medicinal chemistry letters, Aug-01, Volume: 24, Issue:15
Anti-osteoporotic and antioxidant activities of chemical constituents of the aerial parts of Ducrosia ismaelis.
AID401278Increase of nerve growth factor-stimulated neurite growth in rat PC12D cells at 10 to 100 umol after 48 hrs2004Journal of natural products, Apr, Volume: 67, Issue:4
Acetylated flavonoid glycosides potentiating NGF action from Scoparia dulcis.
AID1617647Antiinflammatory activity against LPS-stimulated mouse RAW264.7 cells assessed as decrease in PGE2 production preincubated for 1 hr followed by LPS stimulation and measured after 24 hrs by ELISA
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (9)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (11.11)29.6817
2010's6 (66.67)24.3611
2020's2 (22.22)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 13.13

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index13.13 (24.57)
Research Supply Index2.30 (2.92)
Research Growth Index5.43 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (13.13)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other9 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]